BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30423330)

  • 1. Risk of Second Primary Cancer in Survivors of In Situ Melanoma.
    Kimlin MG; Youlden DR; Brodie AM; DiSipio T; Youl P; Nair-Shalliker V; Baade PD
    J Invest Dermatol; 2019 Apr; 139(4):842-847. PubMed ID: 30423330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
    Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
    JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of second primary cancers after a diagnosis of melanoma.
    Bradford PT; Freedman DM; Goldstein AM; Tucker MA
    Arch Dermatol; 2010 Mar; 146(3):265-72. PubMed ID: 20231496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin.
    Balamurugan A; Rees JR; Kosary C; Rim SH; Li J; Stewart SL
    J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S69-77. PubMed ID: 22018070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
    Spanogle JP; Clarke CA; Aroner S; Swetter SM
    J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries).
    Crocetti E; Guzzinati S; Paci E; Falcini F; Zanetti R; Vercelli M; Rashid I; De Lisi V; Russo A; Vitarelli S; Ferretti S; Mangone L; Cesaraccio R; Tumino R; Pannozzo F
    Melanoma Res; 2008 Jun; 18(3):230-4. PubMed ID: 18477899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
    Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
    J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
    Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
    J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
    Vakharia PP; Kelm RC; Orrell KA; Patel KR; Singam V; Ali Y; Rastogi S; Yousif R; Rangel SM; West DP; Nardone B
    Int J Dermatol; 2020 Apr; 59(4):463-468. PubMed ID: 31971260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
    Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
    Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015.
    Schonfeld SJ; Morton LM; Berrington de González A; Curtis RE; Kitahara CM
    Cancer Epidemiol; 2020 Feb; 64():101664. PubMed ID: 31884334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of developing a second primary cancer in melanoma patients: a comprehensive review of the literature and meta-analysis.
    Caini S; Boniol M; Botteri E; Tosti G; Bazolli B; Russell-Edu W; Giusti F; Testori A; Gandini S
    J Dermatol Sci; 2014 Jul; 75(1):3-9. PubMed ID: 24680127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of second benign brain tumors among cancer survivors in the surveillance, epidemiology, and end results program.
    Kutsenko A; Berrington de Gonzalez A; Curtis RE; Rajaraman P
    Cancer Causes Control; 2014 Jun; 25(6):659-68. PubMed ID: 24682745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
    Cheng Y; Huang Z; Liao Q; Yu X; Jiang H; He Y; Yao S; Nie S; Liu L
    PLoS One; 2020; 15(6):e0232800. PubMed ID: 32497148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between ocular melanoma and other primary cancers: an international population-based study.
    Scélo G; Boffetta P; Autier P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Chia KS; Jonasson JG; Martos C; Giblin M; Brennan P
    Int J Cancer; 2007 Jan; 120(1):152-9. PubMed ID: 17036322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal cell skin cancer and the risk of second primary cancers: a cancer registry-based study in Lithuania.
    Krilaviciute A; Vincerzevskiene I; Smailyte G
    Ann Epidemiol; 2016 Jul; 26(7):511-514. PubMed ID: 27262816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial and ethnic differences in risk of second primary cancers among prostate cancer survivors.
    Withrow DR; Schonfeld SJ; Curtis RE; Morton LM; Cook MB; Butler EN; Berrington de González A
    Cancer Causes Control; 2020 Nov; 31(11):1011-1019. PubMed ID: 32839916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of other primary tumours in patients with oral cancer in Scotland.
    Crosher R; McIlroy R
    Br J Oral Maxillofac Surg; 1998 Feb; 36(1):58-62. PubMed ID: 9578260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries.
    Zhu G; Chen Y; Zhu Z; Lu L; Bi X; Deng Q; Chen X; Su H; Liu Y; Guo H; Zheng T; Yu H; Zhang Y
    Dis Esophagus; 2012 Aug; 25(6):505-11. PubMed ID: 22067063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.